Raphael Pharmaceutical (RAPH) Other financing activities (2022 - 2024)

Raphael Pharmaceutical (RAPH) posted Other financing activities of $50000.0 for Q1 2024, up 400.0% sequentially from $10000.0 in Q1 2022.

Raphael Pharmaceutical (RAPH) Other financing activities (2022 - 2024) Analysis & Trends

Raphael Pharmaceutical has reported Other financing activities for 2 years, with the latest figure at $50000.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Raphael Pharmaceutical	28.25 Mn	28.25 Mn	-

Download Data